Drugs for Neglected Diseases initiative (DNDi) / dndi_transparency-activities
Hepatitis C virus (HCV)
CH-FDJP-CHE110141200-17
EUR 16.18mdeclared budget
EUR 13.60mdisbursed and spent, 1,120 of 1,120 transactions
Implementationstatus
31 Dec 2028planned end
Budget over time
- Reporting organisation
- Drugs for Neglected Diseases initiative (DNDi)
- Start
- 01 Jan 2016 (planned)
- Countries
- —
- Sectors
- Health policy and administrative management (12110) 10%; Medical services (12191) 10%; Basic health infrastructure (12230) 10%; Infectious disease control (12250) 50%; Health education (12261) 5%; Health personnel development (12281) 15%; 121 · OECD DAC 3-digit 20%; 122 · OECD DAC 3-digit 80%; 3 · SDG goal 100%; 3.3 · SDG target 100%; 3.3.5 Number of people requiring interventions against neglected tropical diseases · SDG indicator 100%
- Funded by
- Drugs for Neglected Diseases initiative
- Participating
- Drugs for Neglected Diseases initiative (funding)
- Versions seen
- 2 since 26 Sept 2026 · last checked 2026-10-03 02:26 UTC
Changes
- 2026-10-03Budget changed+1 more
Budget EUR 15.77m → EUR 16.18m (+2.6%)
- Transactions added: 49 transactions added, EUR 418k
Hepatitis C virus (HCV) · compare 0fbd0f94 → 795bcf10
Budgets
| Period | Type | Value | Record |
|---|---|---|---|
| 2019-01-01 → 2019-12-31 | revised, indicative | EUR 4.66m | new since 02 Oct 2026 |
| 2020-01-01 → 2020-12-31 | revised, indicative | EUR 3.53m | new since 02 Oct 2026 |
| 2018-01-01 → 2018-12-31 | revised, indicative | EUR 2.97m | new since 02 Oct 2026 |
| 2021-01-01 → 2021-12-31 | revised, indicative | EUR 2.11m | new since 02 Oct 2026 |
| 2022-01-01 → 2022-12-31 | revised, indicative | EUR 1.21m | new since 02 Oct 2026 |
| 2023-01-01 → 2023-12-31 | revised, indicative | EUR 829k | new since 02 Oct 2026 |
| 2024-01-01 → 2024-12-31 | revised, indicative | EUR 454k | new since 02 Oct 2026 |
| 2025-01-01 → 2025-12-31 | revised, indicative | EUR 409k | new since 02 Oct 2026 |
| 2019-01-01 → 2019-12-31 | original | EUR 4.66m | superseded, last seen 02 Oct 2026 |
| 2020-01-01 → 2020-12-31 | original | EUR 3.53m | superseded, last seen 02 Oct 2026 |
| 2018-01-01 → 2018-12-31 | original | EUR 2.97m | superseded, last seen 02 Oct 2026 |
| 2021-01-01 → 2021-12-31 | original | EUR 2.11m | superseded, last seen 02 Oct 2026 |
| 2022-01-01 → 2022-12-31 | original | EUR 1.21m | superseded, last seen 02 Oct 2026 |
| 2023-01-01 → 2023-12-31 | original | EUR 829k | superseded, last seen 02 Oct 2026 |
| 2024-01-01 → 2024-12-31 | original | EUR 454k | superseded, last seen 02 Oct 2026 |
Transactions
| Date | Type | Value | To | Note | Record |
|---|---|---|---|---|---|
| 2021-01-31 | Expenditure | EUR 1,222 | Drugs for Neglected Diseases initiative | Expenses - 17-2101-1-BE-GB-GOV-1 | |
| 2021-01-31 | Expenditure | EUR 1,570 | Drugs for Neglected Diseases initiative | Expenses - 17-2101-1-BR-GB-GOV-1 | |
| 2021-01-31 | Expenditure | EUR 22k | Drugs for Neglected Diseases initiative | Expenses - 17-2101-1-CH | |
| 2021-01-31 | Expenditure | EUR -22k | Drugs for Neglected Diseases initiative | Expenses - 17-2101-2-CH-CH-4 | |
| 2021-01-31 | Expenditure | EUR 87k | Drugs for Neglected Diseases initiative | Expenses - 17-2101-3-CH-GB-GOV-1 | |
| 2021-01-31 | Expenditure | EUR 6,500 | Drugs for Neglected Diseases initiative | Expenses - 17-2101-1-ES | |
| 2021-01-31 | Expenditure | EUR 69k | Drugs for Neglected Diseases initiative | Expenses - 17-2101-1-FR-GB-GOV-1 | |
| 2021-01-31 | Expenditure | EUR 1,230 | Drugs for Neglected Diseases initiative | Expenses - 17-2101-1-GB-GB-GOV-1 | |
| 2021-01-31 | Expenditure | EUR 549 | Drugs for Neglected Diseases initiative | Expenses - 17-2101-1-MY | |
| 2021-01-31 | Expenditure | EUR 13k | Drugs for Neglected Diseases initiative | Expenses - 17-2101-2-MY-GB-GOV-1 | |
| 2021-01-31 | Expenditure | EUR 7,206 | Drugs for Neglected Diseases initiative | Expenses - 17-2101-1-TH-CH-4 | |
| 2021-01-31 | Expenditure | EUR 1,537 | Drugs for Neglected Diseases initiative | Expenses - 17-2101-1-US-CH-4 | |
| 2021-01-31 | Expenditure | EUR 5,273 | Drugs for Neglected Diseases initiative | Expenses - 17-2101-2-US-GB-GOV-1 | |
| 2021-02-28 | Expenditure | EUR 2,452 | Drugs for Neglected Diseases initiative | Expenses - 17-2102-1-BE-GB-GOV-1 | |
| 2021-02-28 | Expenditure | EUR 1,551 | Drugs for Neglected Diseases initiative | Expenses - 17-2102-1-BR-GB-GOV-1 | |
| 2021-02-28 | Expenditure | EUR 2,706 | Drugs for Neglected Diseases initiative | Expenses - 17-2102-1-CH | |
| 2021-02-28 | Expenditure | EUR 16k | Drugs for Neglected Diseases initiative | Expenses - 17-2102-2-CH | |
| 2021-02-28 | Expenditure | EUR 127 | Drugs for Neglected Diseases initiative | Expenses - 17-2102-3-CH-CH-4 | |
| 2021-02-28 | Expenditure | EUR 67k | Drugs for Neglected Diseases initiative | Expenses - 17-2102-4-CH-GB-GOV-1 | |
| 2021-02-28 | Expenditure | EUR 9,750 | Drugs for Neglected Diseases initiative | Expenses - 17-2102-1-ES | |
| 2021-02-28 | Expenditure | EUR 9,750 | Drugs for Neglected Diseases initiative | Expenses - 17-2102-2-ES-GB-GOV-1 | |
| 2021-02-28 | Expenditure | EUR 1,076 | Drugs for Neglected Diseases initiative | Expenses - 17-2102-1-FR-GB-GOV-1 | |
| 2021-02-28 | Expenditure | EUR 1,391 | Drugs for Neglected Diseases initiative | Expenses - 17-2102-1-GB-GB-GOV-1 | |
| 2021-02-28 | Expenditure | EUR 11k | Drugs for Neglected Diseases initiative | Expenses - 17-2102-1-MY-GB-GOV-1 | |
| 2021-02-28 | Expenditure | EUR 5,826 | Drugs for Neglected Diseases initiative | Expenses - 17-2102-1-TH-GB-GOV-1 | |
| 2021-02-28 | Expenditure | EUR 2,969 | Drugs for Neglected Diseases initiative | Expenses - 17-2102-1-US-GB-GOV-1 | |
| 2021-03-31 | Expenditure | EUR 1,484 | Drugs for Neglected Diseases initiative | Expenses - 17-2103-1-BR-GB-GOV-1 | |
| 2021-03-31 | Expenditure | EUR 320 | Drugs for Neglected Diseases initiative | Expenses - 17-2103-1-CH | |
| 2021-03-31 | Expenditure | EUR 20k | Drugs for Neglected Diseases initiative | Expenses - 17-2103-2-CH | |
| 2021-03-31 | Expenditure | EUR -1,942 | Drugs for Neglected Diseases initiative | Expenses - 17-2103-3-CH-CH-4 | |
| 2021-03-31 | Expenditure | EUR 68k | Drugs for Neglected Diseases initiative | Expenses - 17-2103-4-CH-GB-GOV-1 | |
| 2021-03-31 | Expenditure | EUR 476 | Drugs for Neglected Diseases initiative | Expenses - 17-2103-1-FR | |
| 2021-03-31 | Expenditure | EUR 560 | Drugs for Neglected Diseases initiative | Expenses - 17-2103-2-FR-GB-GOV-1 | |
| 2021-03-31 | Expenditure | EUR 2,461 | Drugs for Neglected Diseases initiative | Expenses - 17-2103-1-GB-GB-GOV-1 | |
| 2021-03-31 | Expenditure | EUR 920 | Drugs for Neglected Diseases initiative | Expenses - 17-2103-1-MY-CH-4 | |
| 2021-03-31 | Expenditure | EUR 12k | Drugs for Neglected Diseases initiative | Expenses - 17-2103-2-MY-GB-GOV-1 | |
| 2021-03-31 | Expenditure | EUR 16k | Drugs for Neglected Diseases initiative | Expenses - 17-2103-1-TH-GB-GOV-1 | |
| 2021-03-31 | Expenditure | EUR 3,303 | Drugs for Neglected Diseases initiative | Expenses - 17-2103-1-US-GB-GOV-1 | |
| 2021-04-30 | Expenditure | EUR 1,484 | Drugs for Neglected Diseases initiative | Expenses - 17-2104-1-BR-GB-GOV-1 | |
| 2021-04-30 | Expenditure | EUR 23k | Drugs for Neglected Diseases initiative | Expenses - 17-2104-1-CH | |
| 2021-04-30 | Expenditure | EUR 45k | Drugs for Neglected Diseases initiative | Expenses - 17-2104-2-CH-GB-GOV-1 | |
| 2021-04-30 | Expenditure | EUR 17k | Drugs for Neglected Diseases initiative | Expenses - 17-2104-1-ES | |
| 2021-04-30 | Expenditure | EUR 11k | Drugs for Neglected Diseases initiative | Expenses - 17-2104-2-ES-GB-GOV-1 | |
| 2021-04-30 | Expenditure | EUR 1,050 | Drugs for Neglected Diseases initiative | Expenses - 17-2104-1-FR-GB-GOV-1 | |
| 2021-04-30 | Expenditure | EUR 5,091 | Drugs for Neglected Diseases initiative | Expenses - 17-2104-1-GB-GB-GOV-1 | |
| 2021-04-30 | Expenditure | EUR 15k | Drugs for Neglected Diseases initiative | Expenses - 17-2104-1-MY-GB-GOV-1 | |
| 2021-04-30 | Expenditure | EUR 2,452 | Drugs for Neglected Diseases initiative | Expenses - 17-2104-1-US-GB-GOV-1 | |
| 2021-05-31 | Expenditure | EUR 2,435 | Drugs for Neglected Diseases initiative | Expenses - 17-2105-1-BE-GB-GOV-1 | |
| 2021-05-31 | Expenditure | EUR 1,625 | Drugs for Neglected Diseases initiative | Expenses - 17-2105-1-BR-GB-GOV-1 | |
| 2021-05-31 | Expenditure | EUR 288 | Drugs for Neglected Diseases initiative | Expenses - 17-2105-1-CH | |
| 2021-05-31 | Expenditure | EUR 25k | Drugs for Neglected Diseases initiative | Expenses - 17-2105-2-CH | |
| 2021-05-31 | Expenditure | EUR 44k | Drugs for Neglected Diseases initiative | Expenses - 17-2105-3-CH-GB-GOV-1 | |
| 2021-05-31 | Expenditure | EUR 217 | Drugs for Neglected Diseases initiative | Expenses - 17-2105-1-ES | |
| 2021-05-31 | Expenditure | EUR 9,750 | Drugs for Neglected Diseases initiative | Expenses - 17-2105-2-ES-GB-GOV-1 | |
| 2021-05-31 | Expenditure | EUR 261 | Drugs for Neglected Diseases initiative | Expenses - 17-2105-1-GB-GB-GOV-1 | |
| 2021-05-31 | Expenditure | EUR 18k | Drugs for Neglected Diseases initiative | Expenses - 17-2105-1-MY-GB-GOV-1 | |
| 2021-05-31 | Expenditure | EUR 2,234 | Drugs for Neglected Diseases initiative | Expenses - 17-2105-1-TH-GB-GOV-1 | |
| 2021-05-31 | Expenditure | EUR 3,627 | Drugs for Neglected Diseases initiative | Expenses - 17-2105-1-US-GB-GOV-1 | |
| 2021-06-30 | Expenditure | EUR 1,728 | Drugs for Neglected Diseases initiative | Expenses - 17-2106-1-BR-GB-GOV-1 | |
| 2021-06-30 | Expenditure | EUR 20k | Drugs for Neglected Diseases initiative | Expenses - 17-2106-1-CH | |
| 2021-06-30 | Expenditure | EUR 54k | Drugs for Neglected Diseases initiative | Expenses - 17-2106-2-CH-GB-GOV-1 | |
| 2021-06-30 | Expenditure | EUR 17k | Drugs for Neglected Diseases initiative | Expenses - 17-2106-1-ES-GB-GOV-1 | |
| 2021-06-30 | Expenditure | EUR 186 | Drugs for Neglected Diseases initiative | Expenses - 17-2106-1-GB-GB-GOV-1 | |
| 2021-06-30 | Expenditure | EUR 55k | Drugs for Neglected Diseases initiative | Expenses - 17-2106-1-MY-GB-GOV-1 | |
| 2021-06-30 | Expenditure | EUR 50k | Drugs for Neglected Diseases initiative | Expenses - 17-2106-1-TH-GB-GOV-1 | |
| 2021-06-30 | Expenditure | EUR 5,953 | Drugs for Neglected Diseases initiative | Expenses - 17-2106-1-US-GB-GOV-1 | |
| 2021-07-31 | Expenditure | EUR 1,712 | Drugs for Neglected Diseases initiative | Expenses - 17-2107-1-BR | |
| 2021-07-31 | Expenditure | EUR 15k | Drugs for Neglected Diseases initiative | Expenses - 17-2107-1-CH | |
| 2021-07-31 | Expenditure | EUR 44k | Drugs for Neglected Diseases initiative | Expenses - 17-2107-2-CH-GB-GOV-1 | |
| 2021-07-31 | Expenditure | EUR 1,016 | Drugs for Neglected Diseases initiative | Expenses - 17-2107-1-GB-GB-GOV-1 | |
| 2021-07-31 | Expenditure | EUR 51k | Drugs for Neglected Diseases initiative | Expenses - 17-2107-1-MY-GB-GOV-1 | |
| 2021-07-31 | Expenditure | EUR 4,672 | Drugs for Neglected Diseases initiative | Expenses - 17-2107-1-TH-GB-GOV-1 | |
| 2021-07-31 | Expenditure | EUR 5,748 | Drugs for Neglected Diseases initiative | Expenses - 17-2107-1-US-GB-GOV-1 | |
| 2021-08-31 | Expenditure | EUR 1,208 | Drugs for Neglected Diseases initiative | Expenses - 17-2108-1-BE-GB-GOV-1 | |
| 2021-08-31 | Expenditure | EUR 1,724 | Drugs for Neglected Diseases initiative | Expenses - 17-2108-1-BR | |
| 2021-08-31 | Expenditure | EUR 15k | Drugs for Neglected Diseases initiative | Expenses - 17-2108-1-CH | |
| 2021-08-31 | Expenditure | EUR 40k | Drugs for Neglected Diseases initiative | Expenses - 17-2108-2-CH-GB-GOV-1 | |
| 2021-08-31 | Expenditure | EUR 5,524 | Drugs for Neglected Diseases initiative | Expenses - 17-2108-1-CN | |
| 2021-08-31 | Expenditure | EUR 8,775 | Drugs for Neglected Diseases initiative | Expenses - 17-2108-1-ES-GB-GOV-1 | |
| 2021-08-31 | Expenditure | EUR 207 | Drugs for Neglected Diseases initiative | Expenses - 17-2108-1-GB-GB-GOV-1 | |
| 2021-08-31 | Expenditure | EUR 1,716 | Drugs for Neglected Diseases initiative | Expenses - 17-2108-1-MY | |
| 2021-08-31 | Expenditure | EUR 9,310 | Drugs for Neglected Diseases initiative | Expenses - 17-2108-2-MY-GB-GOV-1 | |
| 2021-08-31 | Expenditure | EUR 15k | Drugs for Neglected Diseases initiative | Expenses - 17-2108-1-PT-GB-GOV-1 | |
| 2022-01-31 | Expenditure | EUR 617 | Drugs for Neglected Diseases initiative | Expenses - 17-2201-1-BR | |
| 2021-08-31 | Expenditure | EUR 42k | Drugs for Neglected Diseases initiative | Expenses - 17-2108-1-TH-GB-GOV-1 | |
| 2021-08-31 | Expenditure | EUR 4,924 | Drugs for Neglected Diseases initiative | Expenses - 17-2108-1-US-GB-GOV-1 | |
| 2021-09-30 | Expenditure | EUR 1,204 | Drugs for Neglected Diseases initiative | Expenses - 17-2109-1-BE-GB-GOV-1 | |
| 2021-09-30 | Expenditure | EUR 2,382 | Drugs for Neglected Diseases initiative | Expenses - 17-2109-1-BR | |
| 2021-09-30 | Expenditure | EUR 419 | Drugs for Neglected Diseases initiative | Expenses - 17-2109-2-BR-GB-GOV-1 | |
| 2021-09-30 | Expenditure | EUR 375 | Drugs for Neglected Diseases initiative | Expenses - 17-2109-1-CH | |
| 2021-09-30 | Expenditure | EUR 15k | Drugs for Neglected Diseases initiative | Expenses - 17-2109-2-CH | |
| 2021-09-30 | Expenditure | EUR 42k | Drugs for Neglected Diseases initiative | Expenses - 17-2109-3-CH-GB-GOV-1 | |
| 2021-09-30 | Expenditure | EUR 22k | Drugs for Neglected Diseases initiative | Expenses - 17-2109-1-EG-GB-GOV-1 | |
| 2021-09-30 | Expenditure | EUR 8,450 | Drugs for Neglected Diseases initiative | Expenses - 17-2109-1-ES-GB-GOV-1 | |
| 2021-09-30 | Expenditure | EUR 257 | Drugs for Neglected Diseases initiative | Expenses - 17-2109-1-FR-GB-GOV-1 | |
| 2021-09-30 | Expenditure | EUR 200 | Drugs for Neglected Diseases initiative | Expenses - 17-2109-1-IT-GB-GOV-1 | |
| 2021-09-30 | Expenditure | EUR 8,270 | Drugs for Neglected Diseases initiative | Expenses - 17-2109-1-MY-GB-GOV-1 | |
| 2021-09-30 | Expenditure | EUR 118k | Drugs for Neglected Diseases initiative | Expenses - 17-2109-1-TH-GB-GOV-1 | |
| 2021-09-30 | Expenditure | EUR 5,004 | Drugs for Neglected Diseases initiative | Expenses - 17-2109-1-US-GB-GOV-1 | |
| 2021-10-31 | Expenditure | EUR 1,712 | Drugs for Neglected Diseases initiative | Expenses - 17-2110-1-BR | |
| 2021-10-31 | Expenditure | EUR 1,592 | Drugs for Neglected Diseases initiative | Expenses - 17-2110-1-CH | |
| 2021-10-31 | Expenditure | EUR 13k | Drugs for Neglected Diseases initiative | Expenses - 17-2110-2-CH | |
| 2021-10-31 | Expenditure | EUR 44k | Drugs for Neglected Diseases initiative | Expenses - 17-2110-3-CH-GB-GOV-1 | |
| 2021-10-31 | Expenditure | EUR 15k | Drugs for Neglected Diseases initiative | Expenses - 17-2110-1-MY-GB-GOV-1 | |
| 2021-10-31 | Expenditure | EUR 33k | Drugs for Neglected Diseases initiative | Expenses - 17-2110-1-TH-GB-GOV-1 | |
| 2021-10-31 | Expenditure | EUR 27k | Drugs for Neglected Diseases initiative | Expenses - 17-2110-1-US-GB-GOV-1 | |
| 2021-11-30 | Expenditure | EUR 60k | Drugs for Neglected Diseases initiative | Expenses - 17-2111-1-CH-GB-GOV-1 | |
| 2021-11-30 | Expenditure | EUR 405 | Drugs for Neglected Diseases initiative | Expenses - 17-2111-1-FR | |
| 2021-11-30 | Expenditure | EUR 400 | Drugs for Neglected Diseases initiative | Expenses - 17-2111-2-FR-GB-GOV-1 | |
| 2021-11-30 | Expenditure | EUR 242 | Drugs for Neglected Diseases initiative | Expenses - 17-2111-1-GB-GB-GOV-1 | |
| 2021-11-30 | Expenditure | EUR 2,542 | Drugs for Neglected Diseases initiative | Expenses - 17-2111-1-MY | |
| 2021-11-30 | Expenditure | EUR 9,050 | Drugs for Neglected Diseases initiative | Expenses - 17-2111-2-MY-GB-GOV-1 | |
| 2021-11-30 | Expenditure | EUR 8,678 | Drugs for Neglected Diseases initiative | Expenses - 17-2111-1-US-GB-GOV-1 | |
| 2021-12-31 | Expenditure | EUR 1,226 | Drugs for Neglected Diseases initiative | Expenses - 17-2112-1-BE-GB-GOV-1 | |
| 2021-12-31 | Expenditure | EUR 30k | Drugs for Neglected Diseases initiative | Expenses - 17-2112-1-CD-GB-GOV-1 | |
| 2021-12-31 | Expenditure | EUR 42k | Drugs for Neglected Diseases initiative | Expenses - 17-2112-1-CH | |
| 2021-12-31 | Expenditure | EUR 171 | Drugs for Neglected Diseases initiative | Expenses - 17-2112-2-CH | |
| 2021-12-31 | Expenditure | EUR 27k | Drugs for Neglected Diseases initiative | Expenses - 17-2112-3-CH-CH-4 | |
| 2021-12-31 | Expenditure | EUR 175k | Drugs for Neglected Diseases initiative | Expenses - 17-2112-4-CH-GB-GOV-1 | |
| 2021-12-31 | Expenditure | EUR 18k | Drugs for Neglected Diseases initiative | Expenses - 17-2112-1-ES | |
| 2021-12-31 | Expenditure | EUR 1,750 | Drugs for Neglected Diseases initiative | Expenses - 17-2112-1-FR-GB-GOV-1 | |
| 2021-12-31 | Expenditure | EUR 76 | Drugs for Neglected Diseases initiative | Expenses - 17-2112-1-GB-GB-GOV-1 | |
| 2021-12-31 | Expenditure | EUR 9,343 | Drugs for Neglected Diseases initiative | Expenses - 17-2112-1-MY | |
| 2021-12-31 | Expenditure | EUR 36k | Drugs for Neglected Diseases initiative | Expenses - 17-2112-2-MY-GB-GOV-1 | |
| 2021-12-31 | Expenditure | EUR 39k | Drugs for Neglected Diseases initiative | Expenses - 17-2112-1-TH-GB-GOV-1 | |
| 2021-12-31 | Expenditure | EUR 9,355 | Drugs for Neglected Diseases initiative | Expenses - 17-2112-1-US-GB-GOV-1 | |
| 2023-03-31 | Expenditure | EUR 2,841 | Drugs for Neglected Diseases initiative | Expenses - 17-2303-1-MY | |
| 2023-03-31 | Expenditure | EUR 6,063 | Drugs for Neglected Diseases initiative | Expenses - 17-2303-2-MY-GB-GOV-1 | |
| 2023-03-31 | Expenditure | EUR 7,802 | Drugs for Neglected Diseases initiative | Expenses - 17-2303-1-TH-GB-GOV-1 | |
| 2023-03-31 | Expenditure | EUR 1,233 | Drugs for Neglected Diseases initiative | Expenses - 17-2303-1-US | |
| 2023-03-31 | Expenditure | EUR 632 | Drugs for Neglected Diseases initiative | Expenses - 17-2303-2-US-GB-GOV-1 | |
| 2023-04-30 | Expenditure | EUR 811 | Drugs for Neglected Diseases initiative | Expenses - 17-2304-1-BR-GB-GOV-1 | |
| 2023-04-30 | Expenditure | EUR 25k | Drugs for Neglected Diseases initiative | Expenses - 17-2304-1-CH-GB-GOV-1 | |
| 2023-04-30 | Expenditure | EUR 7,150 | Drugs for Neglected Diseases initiative | Expenses - 17-2304-1-ES | |
| 2023-04-30 | Expenditure | EUR 10k | Drugs for Neglected Diseases initiative | Expenses - 17-2304-1-MY | |
| 2023-04-30 | Expenditure | EUR 6,035 | Drugs for Neglected Diseases initiative | Expenses - 17-2304-2-MY-GB-GOV-1 | |
| 2023-04-30 | Expenditure | EUR 1,662 | Drugs for Neglected Diseases initiative | Expenses - 17-2304-1-TH-GB-GOV-1 | |
| 2023-04-30 | Expenditure | EUR 1,345 | Drugs for Neglected Diseases initiative | Expenses - 17-2304-1-US | |
| 2023-04-30 | Expenditure | EUR 787 | Drugs for Neglected Diseases initiative | Expenses - 17-2304-2-US-GB-GOV-1 | |
| 2023-05-31 | Expenditure | EUR 4,111 | Drugs for Neglected Diseases initiative | Expenses - 17-2305-1-BR | |
| 2023-05-31 | Expenditure | EUR 837 | Drugs for Neglected Diseases initiative | Expenses - 17-2305-2-BR-GB-GOV-1 | |
| 2023-05-31 | Expenditure | EUR 12k | Drugs for Neglected Diseases initiative | Expenses - 17-2305-1-CH | |
| 2023-05-31 | Expenditure | EUR 4,951 | Drugs for Neglected Diseases initiative | Expenses - 17-2305-2-CH-GB-GOV-1 | |
| 2023-05-31 | Expenditure | EUR 7,150 | Drugs for Neglected Diseases initiative | Expenses - 17-2305-1-ES | |
| 2023-05-31 | Expenditure | EUR 4,120 | Drugs for Neglected Diseases initiative | Expenses - 17-2305-1-MY | |
| 2023-05-31 | Expenditure | EUR 6,767 | Drugs for Neglected Diseases initiative | Expenses - 17-2305-2-MY-GB-GOV-1 | |
| 2023-05-31 | Expenditure | EUR 68k | Drugs for Neglected Diseases initiative | Expenses - 17-2305-1-TH-GB-GOV-1 | |
| 2023-05-31 | Expenditure | EUR 1,642 | Drugs for Neglected Diseases initiative | Expenses - 17-2305-1-US | |
| 2023-05-31 | Expenditure | EUR 616 | Drugs for Neglected Diseases initiative | Expenses - 17-2305-2-US-GB-GOV-1 | |
| 2023-06-30 | Expenditure | EUR 24k | Drugs for Neglected Diseases initiative | Expenses - 17-2306-1-BR | |
| 2023-06-30 | Expenditure | EUR 859 | Drugs for Neglected Diseases initiative | Expenses - 17-2306-2-BR-GB-GOV-1 | |
| 2023-06-30 | Expenditure | EUR 12k | Drugs for Neglected Diseases initiative | Expenses - 17-2306-1-CH | |
| 2023-06-30 | Expenditure | EUR 26k | Drugs for Neglected Diseases initiative | Expenses - 17-2306-2-CH-GB-GOV-1 | |
| 2023-06-30 | Expenditure | EUR 9,890 | Drugs for Neglected Diseases initiative | Expenses - 17-2306-1-ES | |
| 2023-06-30 | Expenditure | EUR 790 | Drugs for Neglected Diseases initiative | Expenses - 17-2306-1-FR | |
| 2023-06-30 | Expenditure | EUR 27k | Drugs for Neglected Diseases initiative | Expenses - 17-2306-1-MY | |
| 2023-06-30 | Expenditure | EUR 6,612 | Drugs for Neglected Diseases initiative | Expenses - 17-2306-2-MY-GB-GOV-1 | |
| 2023-06-30 | Expenditure | EUR 30k | Drugs for Neglected Diseases initiative | Expenses - 17-2306-1-US | |
| 2023-06-30 | Expenditure | EUR 5,680 | Drugs for Neglected Diseases initiative | Expenses - 17-2306-2-US-GB-GOV-1 | |
| 2023-07-31 | Expenditure | EUR 956 | Drugs for Neglected Diseases initiative | Expenses - 17-2307-1-BR-GB-GOV-1 | |
| 2023-07-31 | Expenditure | EUR 24k | Drugs for Neglected Diseases initiative | Expenses - 17-2307-1-CH-GB-GOV-1 | |
| 2023-07-31 | Expenditure | EUR 3,900 | Drugs for Neglected Diseases initiative | Expenses - 17-2307-1-ES-GB-GOV-1 | |
| 2023-07-31 | Expenditure | EUR 6,797 | Drugs for Neglected Diseases initiative | Expenses - 17-2307-1-MY-GB-GOV-1 | |
| 2023-07-31 | Expenditure | EUR 684 | Drugs for Neglected Diseases initiative | Expenses - 17-2307-1-US-GB-GOV-1 | |
| 2023-08-31 | Expenditure | EUR 1,504 | Drugs for Neglected Diseases initiative | Expenses - 17-2308-1-BR | |
| 2023-08-31 | Expenditure | EUR 883 | Drugs for Neglected Diseases initiative | Expenses - 17-2308-2-BR-CH-4 | |
| 2023-08-31 | Expenditure | EUR 4,138 | Drugs for Neglected Diseases initiative | Expenses - 17-2308-1-CH | |
| 2023-08-31 | Expenditure | EUR 18k | Drugs for Neglected Diseases initiative | Expenses - 17-2308-2-CH-CH-4 | |
| 2022-01-31 | Expenditure | EUR 1,372 | Drugs for Neglected Diseases initiative | Expenses - 17-2201-1-CH | |
| 2022-01-31 | Expenditure | EUR 31k | Drugs for Neglected Diseases initiative | Expenses - 17-2201-2-CH | |
| 2022-01-31 | Expenditure | EUR 18k | Drugs for Neglected Diseases initiative | Expenses - 17-2201-3-CH-GB-GOV-1 | |
| 2022-01-31 | Expenditure | EUR 220 | Drugs for Neglected Diseases initiative | Expenses - 17-2201-1-MY | |
| 2022-01-31 | Expenditure | EUR 6,646 | Drugs for Neglected Diseases initiative | Expenses - 17-2201-2-MY | |
| 2022-01-31 | Expenditure | EUR 2,014 | Drugs for Neglected Diseases initiative | Expenses - 17-2201-1-TH | |
| 2022-01-31 | Expenditure | EUR 2,629 | Drugs for Neglected Diseases initiative | Expenses - 17-2201-1-US | |
| 2022-02-28 | Expenditure | EUR 631 | Drugs for Neglected Diseases initiative | Expenses - 17-2202-1-BR | |
| 2022-02-28 | Expenditure | EUR 10k | Drugs for Neglected Diseases initiative | Expenses - 17-2202-1-CH | |
| 2022-02-28 | Expenditure | EUR 10k | Drugs for Neglected Diseases initiative | Expenses - 17-2202-2-CH | |
| 2022-02-28 | Expenditure | EUR 32k | Drugs for Neglected Diseases initiative | Expenses - 17-2202-3-CH | |
| 2022-02-28 | Expenditure | EUR 20k | Drugs for Neglected Diseases initiative | Expenses - 17-2202-1-ES | |
| 2022-02-28 | Expenditure | EUR 142 | Drugs for Neglected Diseases initiative | Expenses - 17-2202-1-MY | |
| 2022-02-28 | Expenditure | EUR 6,708 | Drugs for Neglected Diseases initiative | Expenses - 17-2202-2-MY | |
| 2022-02-28 | Expenditure | EUR 2,020 | Drugs for Neglected Diseases initiative | Expenses - 17-2202-1-US | |
| 2022-03-31 | Expenditure | EUR 438 | Drugs for Neglected Diseases initiative | Expenses - 17-2203-1-BR | |
| 2022-03-31 | Expenditure | EUR 245 | Drugs for Neglected Diseases initiative | Expenses - 17-2203-2-BR-CH-4 | |
| 2022-03-31 | Expenditure | EUR 5,054 | Drugs for Neglected Diseases initiative | Expenses - 17-2203-1-CH | |
| 2022-03-31 | Expenditure | EUR 11k | Drugs for Neglected Diseases initiative | Expenses - 17-2203-2-CH | |
| 2022-03-31 | Expenditure | EUR 32k | Drugs for Neglected Diseases initiative | Expenses - 17-2203-3-CH | |
| 2022-03-31 | Expenditure | EUR 11k | Drugs for Neglected Diseases initiative | Expenses - 17-2203-1-ES | |
| 2022-03-31 | Expenditure | EUR 300 | Drugs for Neglected Diseases initiative | Expenses - 17-2203-1-FR | |
| 2022-03-31 | Expenditure | EUR 1,140 | Drugs for Neglected Diseases initiative | Expenses - 17-2203-1-MY | |
| 2022-03-31 | Expenditure | EUR 228 | Drugs for Neglected Diseases initiative | Expenses - 17-2203-2-MY | |
| 2022-03-31 | Expenditure | EUR 9,149 | Drugs for Neglected Diseases initiative | Expenses - 17-2203-3-MY | |
| 2022-03-31 | Expenditure | EUR 1,269 | Drugs for Neglected Diseases initiative | Expenses - 17-2203-1-US | |
| 2022-03-31 | Expenditure | EUR 3,022 | Drugs for Neglected Diseases initiative | Expenses - 17-2203-2-US | |
| 2022-04-30 | Expenditure | EUR 793 | Drugs for Neglected Diseases initiative | Expenses - 17-2204-1-BR-GB-GOV-1 | |
| 2022-04-30 | Expenditure | EUR 2,003 | Drugs for Neglected Diseases initiative | Expenses - 17-2204-1-CH | |
| 2022-04-30 | Expenditure | EUR 1,566 | Drugs for Neglected Diseases initiative | Expenses - 17-2204-2-CH | |
| 2022-04-30 | Expenditure | EUR 40k | Drugs for Neglected Diseases initiative | Expenses - 17-2204-3-CH-GB-GOV-1 | |
| 2022-04-30 | Expenditure | EUR 9,100 | Drugs for Neglected Diseases initiative | Expenses - 17-2204-1-ES | |
| 2022-04-30 | Expenditure | EUR 6,071 | Drugs for Neglected Diseases initiative | Expenses - 17-2204-1-FR-GB-GOV-1 | |
| 2022-04-30 | Expenditure | EUR 12k | Drugs for Neglected Diseases initiative | Expenses - 17-2204-1-GB-GB-GOV-1 | |
| 2022-04-30 | Expenditure | EUR 1,366 | Drugs for Neglected Diseases initiative | Expenses - 17-2204-1-MY | |
| 2022-04-30 | Expenditure | EUR 38k | Drugs for Neglected Diseases initiative | Expenses - 17-2204-2-MY-GB-GOV-1 | |
| 2022-04-30 | Expenditure | EUR 12k | Drugs for Neglected Diseases initiative | Expenses - 17-2204-1-TZ-GB-GOV-1 | |
| 2022-04-30 | Expenditure | EUR 1,398 | Drugs for Neglected Diseases initiative | Expenses - 17-2204-1-US | |
| 2022-04-30 | Expenditure | EUR 4,394 | Drugs for Neglected Diseases initiative | Expenses - 17-2204-2-US-GB-GOV-1 | |
| 2022-05-31 | Expenditure | EUR 780 | Drugs for Neglected Diseases initiative | Expenses - 17-2205-1-BR-GB-GOV-1 | |
| 2022-05-31 | Expenditure | EUR 2,010 | Drugs for Neglected Diseases initiative | Expenses - 17-2205-1-CH | |
| 2022-05-31 | Expenditure | EUR 129 | Drugs for Neglected Diseases initiative | Expenses - 17-2205-2-CH | |
| 2022-05-31 | Expenditure | EUR 4,414 | Drugs for Neglected Diseases initiative | Expenses - 17-2205-3-CH | |
| 2022-05-31 | Expenditure | EUR 42k | Drugs for Neglected Diseases initiative | Expenses - 17-2205-4-CH-GB-GOV-1 | |
| 2022-05-31 | Expenditure | EUR 9,750 | Drugs for Neglected Diseases initiative | Expenses - 17-2205-1-ES | |
| 2022-05-31 | Expenditure | EUR 4,207 | Drugs for Neglected Diseases initiative | Expenses - 17-2205-1-FR-GB-GOV-1 | |
| 2022-05-31 | Expenditure | EUR 120 | Drugs for Neglected Diseases initiative | Expenses - 17-2205-1-IN | |
| 2022-05-31 | Expenditure | EUR 742 | Drugs for Neglected Diseases initiative | Expenses - 17-2205-1-MY | |
| 2022-05-31 | Expenditure | EUR 11k | Drugs for Neglected Diseases initiative | Expenses - 17-2205-2-MY-GB-GOV-1 | |
| 2022-05-31 | Expenditure | EUR 1,333 | Drugs for Neglected Diseases initiative | Expenses - 17-2205-1-US | |
| 2022-05-31 | Expenditure | EUR 3,697 | Drugs for Neglected Diseases initiative | Expenses - 17-2205-2-US-GB-GOV-1 | |
| 2022-06-30 | Expenditure | EUR 60 | Drugs for Neglected Diseases initiative | Expenses - 17-2206-1-BR | |
| 2022-06-30 | Expenditure | EUR 585 | Drugs for Neglected Diseases initiative | Expenses - 17-2206-2-BR-GB-GOV-1 | |
| 2022-06-30 | Expenditure | EUR 1,981 | Drugs for Neglected Diseases initiative | Expenses - 17-2206-1-CH | |
| 2022-06-30 | Expenditure | EUR 45k | Drugs for Neglected Diseases initiative | Expenses - 17-2206-2-CH | |
| 2022-06-30 | Expenditure | EUR 38k | Drugs for Neglected Diseases initiative | Expenses - 17-2206-3-CH-GB-GOV-1 | |
| 2022-06-30 | Expenditure | EUR 7,150 | Drugs for Neglected Diseases initiative | Expenses - 17-2206-1-ES | |
| 2022-06-30 | Expenditure | EUR 870 | Drugs for Neglected Diseases initiative | Expenses - 17-2206-1-FR-GB-GOV-1 | |
| 2022-06-30 | Expenditure | EUR 129 | Drugs for Neglected Diseases initiative | Expenses - 17-2206-1-GB-GB-GOV-1 | |
| 2022-06-30 | Expenditure | EUR 821 | Drugs for Neglected Diseases initiative | Expenses - 17-2206-1-MY | |
| 2022-06-30 | Expenditure | EUR 6,151 | Drugs for Neglected Diseases initiative | Expenses - 17-2206-2-MY-GB-GOV-1 | |
| 2022-06-30 | Expenditure | EUR 1,401 | Drugs for Neglected Diseases initiative | Expenses - 17-2206-1-US | |
| 2022-06-30 | Expenditure | EUR 3,718 | Drugs for Neglected Diseases initiative | Expenses - 17-2206-2-US-GB-GOV-1 | |
| 2022-07-31 | Expenditure | EUR 622 | Drugs for Neglected Diseases initiative | Expenses - 17-2207-1-BR-GB-GOV-1 | |
| 2022-07-31 | Expenditure | EUR 2,003 | Drugs for Neglected Diseases initiative | Expenses - 17-2207-1-CH | |
| 2022-07-31 | Expenditure | EUR 40k | Drugs for Neglected Diseases initiative | Expenses - 17-2207-2-CH-GB-GOV-1 | |
| 2022-07-31 | Expenditure | EUR 7,800 | Drugs for Neglected Diseases initiative | Expenses - 17-2207-1-ES | |
| 2022-07-31 | Expenditure | EUR 3,373 | Drugs for Neglected Diseases initiative | Expenses - 17-2207-1-MY | |
| 2022-07-31 | Expenditure | EUR 6,571 | Drugs for Neglected Diseases initiative | Expenses - 17-2207-2-MY-GB-GOV-1 | |
| 2022-07-31 | Expenditure | EUR 1,136 | Drugs for Neglected Diseases initiative | Expenses - 17-2207-1-US | |
| 2022-07-31 | Expenditure | EUR 14k | Drugs for Neglected Diseases initiative | Expenses - 17-2207-2-US-GB-GOV-1 | |
| 2022-08-31 | Expenditure | EUR 632 | Drugs for Neglected Diseases initiative | Expenses - 17-2208-1-BR | |
| 2022-08-31 | Expenditure | EUR 863 | Drugs for Neglected Diseases initiative | Expenses - 17-2208-2-BR-GB-GOV-1 | |
| 2022-08-31 | Expenditure | EUR 2,078 | Drugs for Neglected Diseases initiative | Expenses - 17-2208-1-CH | |
| 2022-08-31 | Expenditure | EUR 1,841 | Drugs for Neglected Diseases initiative | Expenses - 17-2208-2-CH | |
| 2022-08-31 | Expenditure | EUR 32k | Drugs for Neglected Diseases initiative | Expenses - 17-2208-3-CH-GB-GOV-1 | |
| 2022-08-31 | Expenditure | EUR 5,200 | Drugs for Neglected Diseases initiative | Expenses - 17-2208-1-ES | |
| 2022-08-31 | Expenditure | EUR 4,366 | Drugs for Neglected Diseases initiative | Expenses - 17-2208-1-MY | |
| 2022-08-31 | Expenditure | EUR 7,655 | Drugs for Neglected Diseases initiative | Expenses - 17-2208-2-MY-GB-GOV-1 | |
| 2022-08-31 | Expenditure | EUR 32k | Drugs for Neglected Diseases initiative | Expenses - 17-2208-1-TH-GB-GOV-1 | |
| 2022-08-31 | Expenditure | EUR 1,650 | Drugs for Neglected Diseases initiative | Expenses - 17-2208-1-US | |
| 2022-08-31 | Expenditure | EUR 9,937 | Drugs for Neglected Diseases initiative | Expenses - 17-2208-2-US-GB-GOV-1 | |
| 2022-09-30 | Expenditure | EUR 674 | Drugs for Neglected Diseases initiative | Expenses - 17-2209-1-BR | |
| 2022-09-30 | Expenditure | EUR 3,003 | Drugs for Neglected Diseases initiative | Expenses - 17-2209-2-BR | |
| 2022-09-30 | Expenditure | EUR 20k | Drugs for Neglected Diseases initiative | Expenses - 17-2209-1-CH | |
| 2022-09-30 | Expenditure | EUR 3,303 | Drugs for Neglected Diseases initiative | Expenses - 17-2209-2-CH | |
| 2022-09-30 | Expenditure | EUR 3,044 | Drugs for Neglected Diseases initiative | Expenses - 17-2209-3-CH-CH-4 | |
| 2022-09-30 | Expenditure | EUR 6,503 | Drugs for Neglected Diseases initiative | Expenses - 17-2209-4-CH-GB-GOV-1 | |
| 2022-09-30 | Expenditure | EUR 7,150 | Drugs for Neglected Diseases initiative | Expenses - 17-2209-1-ES | |
| 2022-09-30 | Expenditure | EUR 3,439 | Drugs for Neglected Diseases initiative | Expenses - 17-2209-1-FR | |
| 2022-09-30 | Expenditure | EUR 2,972 | Drugs for Neglected Diseases initiative | Expenses - 17-2209-1-KE | |
| 2022-09-30 | Expenditure | EUR 7,183 | Drugs for Neglected Diseases initiative | Expenses - 17-2209-1-MY | |
| 2022-09-30 | Expenditure | EUR 3,316 | Drugs for Neglected Diseases initiative | Expenses - 17-2209-2-MY | |
| 2022-09-30 | Expenditure | EUR 32k | Drugs for Neglected Diseases initiative | Expenses - 17-2209-3-MY | |
| 2022-09-30 | Expenditure | EUR 318 | Drugs for Neglected Diseases initiative | Expenses - 17-2209-4-MY-GB-GOV-1 | |
| 2022-09-30 | Expenditure | EUR 961 | Drugs for Neglected Diseases initiative | Expenses - 17-2209-1-US | |
| 2022-09-30 | Expenditure | EUR 1,421 | Drugs for Neglected Diseases initiative | Expenses - 17-2209-2-US | |
| 2022-09-30 | Expenditure | EUR 12k | Drugs for Neglected Diseases initiative | Expenses - 17-2209-3-US | |
| 2022-10-31 | Expenditure | EUR 662 | Drugs for Neglected Diseases initiative | Expenses - 17-2210-1-BR | |
| 2022-10-31 | Expenditure | EUR 2,159 | Drugs for Neglected Diseases initiative | Expenses - 17-2210-2-BR | |
| 2022-10-31 | Expenditure | EUR 28k | Drugs for Neglected Diseases initiative | Expenses - 17-2210-1-CH | |
| 2022-10-31 | Expenditure | EUR 40k | Drugs for Neglected Diseases initiative | Expenses - 17-2210-2-CH | |
| 2022-10-31 | Expenditure | EUR 2,812 | Drugs for Neglected Diseases initiative | Expenses - 17-2210-3-CH | |
| 2022-10-31 | Expenditure | EUR 1,435 | Drugs for Neglected Diseases initiative | Expenses - 17-2210-4-CH-GB-GOV-1 | |
| 2022-10-31 | Expenditure | EUR 9,750 | Drugs for Neglected Diseases initiative | Expenses - 17-2210-1-ES | |
| 2022-10-31 | Expenditure | EUR 641 | Drugs for Neglected Diseases initiative | Expenses - 17-2210-1-FR | |
| 2022-10-31 | Expenditure | EUR 4,154 | Drugs for Neglected Diseases initiative | Expenses - 17-2210-1-KE | |
| 2022-10-31 | Expenditure | EUR 8,359 | Drugs for Neglected Diseases initiative | Expenses - 17-2210-1-MY | |
| 2022-10-31 | Expenditure | EUR 8,790 | Drugs for Neglected Diseases initiative | Expenses - 17-2210-2-MY | |
| 2022-10-31 | Expenditure | EUR 401 | Drugs for Neglected Diseases initiative | Expenses - 17-2210-3-MY-GB-GOV-1 | |
| 2022-10-31 | Expenditure | EUR 9,951 | Drugs for Neglected Diseases initiative | Expenses - 17-2210-1-US | |
| 2022-10-31 | Expenditure | EUR 1,455 | Drugs for Neglected Diseases initiative | Expenses - 17-2210-2-US | |
| 2022-11-30 | Expenditure | EUR 2,532 | Drugs for Neglected Diseases initiative | Expenses - 17-2211-1-BR | |
| 2022-11-30 | Expenditure | EUR 740 | Drugs for Neglected Diseases initiative | Expenses - 17-2211-2-BR | |
| 2022-11-30 | Expenditure | EUR 3,320 | Drugs for Neglected Diseases initiative | Expenses - 17-2211-1-CH | |
| 2022-11-30 | Expenditure | EUR 1,120 | Drugs for Neglected Diseases initiative | Expenses - 17-2211-2-CH | |
| 2022-11-30 | Expenditure | EUR 24k | Drugs for Neglected Diseases initiative | Expenses - 17-2211-3-CH | |
| 2022-11-30 | Expenditure | EUR 1,411 | Drugs for Neglected Diseases initiative | Expenses - 17-2211-4-CH-GB-GOV-1 | |
| 2022-11-30 | Expenditure | EUR 6,500 | Drugs for Neglected Diseases initiative | Expenses - 17-2211-1-ES | |
| 2022-11-30 | Expenditure | EUR 224 | Drugs for Neglected Diseases initiative | Expenses - 17-2211-1-FR | |
| 2022-11-30 | Expenditure | EUR 900 | Drugs for Neglected Diseases initiative | Expenses - 17-2211-2-FR | |
| 2022-11-30 | Expenditure | EUR 440 | Drugs for Neglected Diseases initiative | Expenses - 17-2211-1-MY | |
| 2022-11-30 | Expenditure | EUR 6,092 | Drugs for Neglected Diseases initiative | Expenses - 17-2211-2-MY | |
| 2022-11-30 | Expenditure | EUR 662 | Drugs for Neglected Diseases initiative | Expenses - 17-2211-3-MY-GB-GOV-1 | |
| 2022-11-30 | Expenditure | EUR 1,104 | Drugs for Neglected Diseases initiative | Expenses - 17-2211-1-TH | |
| 2022-11-30 | Expenditure | EUR 1,463 | Drugs for Neglected Diseases initiative | Expenses - 17-2211-1-US | |
| 2022-11-30 | Expenditure | EUR 2,693 | Drugs for Neglected Diseases initiative | Expenses - 17-2211-2-US | |
| 2022-12-31 | Expenditure | EUR 334 | Drugs for Neglected Diseases initiative | Expenses - 17-2212-1-BR | |
| 2022-12-31 | Expenditure | EUR 3,624 | Drugs for Neglected Diseases initiative | Expenses - 17-2212-2-BR | |
| 2022-12-31 | Expenditure | EUR 1,185 | Drugs for Neglected Diseases initiative | Expenses - 17-2212-3-BR | |
| 2022-12-31 | Expenditure | EUR 5,506 | Drugs for Neglected Diseases initiative | Expenses - 17-2212-1-CH | |
| 2022-12-31 | Expenditure | EUR 68k | Drugs for Neglected Diseases initiative | Expenses - 17-2212-2-CH |
Showing 300 of 1,120. The API returns all of them.
Struck-through rows were in the previous version, last seen 2026-10-02 02:19 UTC, and are not in the current file.